Celcuity (CELC) Shares Outstanding (2016 - 2026)
Celcuity's (CELC) quarterly Shares Outstanding (Entity) came in at $48.2 million in Q4 2025, up 29.89% YoY from $37.1 million in Q4 2024, and up 11.49% on a QoQ basis from $43.3 million in Q3 2025.
Celcuity (CELC) Shares Outstanding (2016 - 2026) Analysis & Trends
Celcuity (CELC) has 10 years of Shares Outstanding (Entity) data on file, last reported at $48.2 million in Q4 2025.
- Quarterly Shares Outstanding (Entity) rose 29.89% year-over-year to $48.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $48.2 million (up 29.89% YoY) and the FY2025 annual result came in at $48.2 million, up 29.89% from the prior year.
- Shares Outstanding (Entity) climbed to $48.2 million in Q4 2025, from $43.3 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $48.2 million in Q4 2025 to a low of $12.3 million in Q1 2021.
- A 5-year average of $25.9 million and a median of $22.2 million in 2023 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) grew 0.25% — and 2024, when it soared 67.62%.
- Tracing CELC's Shares Outstanding (Entity) over 5 years: stood at $14.9 million in 2021, then grew by 3.35% to $15.4 million in 2022, then surged by 65.42% to $25.5 million in 2023, then jumped by 45.63% to $37.1 million in 2024, then rose by 29.89% to $48.2 million in 2025.
- The last three Shares Outstanding (Entity) figures came in at $48.2 million (Q4 2025), $43.3 million (Q3 2025), and $38.9 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 62.19 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 210.89 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.45 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.05 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 445.06 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 133.61 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Celcuity | 4.50 Bn | 4.50 Bn | - | 54.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 54.82 Mn |
| Dec 31, 2025 | 46.76 Mn |
| Sep 30, 2025 | 47.59 Mn |
| Jun 30, 2025 | 43.66 Mn |
| Mar 31, 2025 | 43.05 Mn |
| Dec 31, 2024 | 39.45 Mn |
| Sep 30, 2024 | 42.79 Mn |
| Jun 30, 2024 | 38.44 Mn |
| Mar 31, 2024 | 33.61 Mn |
| Dec 31, 2023 | 23.68 Mn |
| Sep 30, 2023 | 22.12 Mn |
| Jun 30, 2023 | 21.96 Mn |
| Mar 31, 2023 | 21.68 Mn |
| Dec 31, 2022 | 15.42 Mn |
| Sep 30, 2022 | 14.94 Mn |
| Jun 30, 2022 | 14.93 Mn |
| Mar 31, 2022 | 14.92 Mn |
| Dec 31, 2021 | 13.38 Mn |
| Sep 30, 2021 | 14.88 Mn |
| Jun 30, 2021 | 12.61 Mn |